-
-
-
-
-
-
-
Evercore ISI Resumes BioCryst Pharma (BCRX) at Outperform, Adds to Core SMID list
-
-
-
-
-
-
-
BioCryst receives antitrust clearance for Astria acquisition
-
-
-
-
-
-
-
Oppenheimer Downgrades Astria Therapeutics (ATXS) to Perform
-
-
-
-
-
-
-
BioCryst Announces Sale of European ORLADEYO® (berotralstat) Business to Neopharmed Gentili for up to $264 Million
-
-
-
-
-
-
-
Pre-Open Stock Movers 1/28: (DLPH) (XLRN) (ALKS) Higher (EROS) (BWA) (DDD) Lower (more...)
-
-
-
-
-
-
-
BioCryst Reports Fourth Quarter and Full Year 2018 Financial Results
-
-
-
-
-
-
-
BioCryst Provides Update on Strategy, Pipeline and Outlook
-
1,170,679 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

